RadNet, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>RadNet, Inc. has filed its Q1 2024 10-Q report, detailing financial performance and operations.</b>

AI Summary

RadNet, Inc. (RDNT) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. RadNet, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing covers the first quarter of 2024. The company's fiscal year ends on December 31st. RadNet, Inc. is classified under SERVICES-MEDICAL LABORATORIES. The filing was submitted on May 10, 2024.

Why It Matters

For investors and stakeholders tracking RadNet, Inc., this filing contains several important signals. This 10-Q filing provides investors with the latest quarterly financial data, including revenue, expenses, and balance sheet information, crucial for assessing the company's current financial health and performance trends. Understanding the details within this report allows stakeholders to evaluate RadNet's operational efficiency, profitability, and any potential risks or opportunities that may impact future growth and shareholder value.

Risk Assessment

Risk Level: low — RadNet, Inc. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate red flags or significant deviations from typical reporting, indicating a low level of immediate risk.

Analyst Insight

Review the detailed financial statements and management's discussion and analysis within the 10-Q to understand RadNet's Q1 2024 performance and outlook.

Key Numbers

• 2024-03-31 — Period End Date (Conformed period of report)
• 2024-05-10 — Filing Date (Date the 10-Q was filed)
• Q1 2024 — Reporting Quarter (Indicates the period covered by the report)
• 8071 — SIC Code (Standard Industrial Classification for Medical Laboratories)

Key Players & Entities

• RadNet, Inc. (company) — Filer of the 10-Q report
• 2024-03-31 (date) — Conformed period of report
• 2024-05-10 (date) — Filed as of date
• 0000790526 (company) — Central Index Key for RadNet, Inc.
• SERVICES-MEDICAL LABORATORIES (industry) — Standard Industrial Classification
• 1510 COTNER AVE (address) — Business and mailing address
• LOS ANGELES (location) — City for business and mailing address
• DE (location) — State of incorporation

FAQ

Industry Context

RadNet, Inc. operates within the medical laboratories sector, providing diagnostic imaging services.

Regulatory Implications

As a publicly traded company, RadNet, Inc. is subject to SEC regulations and reporting requirements, including the filing of quarterly 10-Q reports.

What Investors Should Do

1. Analyze RadNet's revenue streams and growth drivers for Q1 2024.
2. Examine RadNet's operating expenses and cost management strategies.
3. Assess RadNet's balance sheet for liquidity, solvency, and capital structure.

Key Dates

• 2024-03-31: Quarterly Period End — Marks the end of the reporting period for the 10-Q.
• 2024-05-10: Filing Date — Date RadNet, Inc. submitted its 10-Q filing.

Year-Over-Year Comparison

This is the initial filing analyzed for the specified period, so no comparison to a previous filing is available.

Filing Documents

• rdnt-20240331.htm (10-Q) — 1313KB
• q12024exhibit311.htm (EX-31.1) — 16KB
• q12024exhibit312.htm (EX-31.2) — 17KB
• q12024exhibit321.htm (EX-32.1) — 7KB
• q12024exhibit322.htm (EX-32.2) — 6KB
• 0001628280-24-022619.txt (&nbsp;) — 7945KB
• rdnt-20240331.xsd (EX-101.SCH) — 48KB
• rdnt-20240331_cal.xml (EX-101.CAL) — 70KB
• rdnt-20240331_def.xml (EX-101.DEF) — 390KB
• rdnt-20240331_lab.xml (EX-101.LAB) — 722KB
• rdnt-20240331_pre.xml (EX-101.PRE) — 534KB
• rdnt-20240331_htm.xml (XML) — 1124KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 1

Financial Statements

ITEM 1. Financial Statements 1 Condensed Consolidated Balance Sheets at March 31, 2024 and December 31, 2023 1 Condensed Consolidated Statements of Operations for the Three Months Ended March 31 , 202 4 and 20 23 1 Condensed Consolidated Statements of Comprehensive I ncome ( Loss ) for the Three Months Ended March 3 1 , 202 4 and 202 3 3 Condensed Consolidated Statement of Stockholders' Equity for the Three Months Ended March 31 , 202 4 and 202 3 4 Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 3 1 , 202 4 and 20 23 6 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 24

Quantitative and Qualitative Disclosures About Market Risk

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 36

Controls and Procedures

ITEM 4. Controls and Procedures 37

– OTHER INFORMATION

PART II – OTHER INFORMATION 38

Legal Proceedings

ITEM 1. Legal Proceedings 38

Risk Factors

ITEM 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Defaults Upon Senior Securities

ITEM 3. Defaults Upon Senior Securities 38

Mine Safety Disclosures

ITEM 4. Mine Safety Disclosures 38

Other Information

ITEM 5. Other Information 38

Exhibits

ITEM 6. Exhibits 38

SIGNATURES

SIGNATURES 39 i Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

– Financial Statements

Item 1 – Financial Statements RADNET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA) March 31, 2024 December 31, 2023 (unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 526,980 $ 342,570 Accounts receivable 189,572 163,707 Due from affiliates 34,269 25,342 Prepaid expenses and other current assets 45,007 47,657 Total current assets 795,828 579,276 PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS Property and equipment, net 618,926 604,401 Operating lease right-of-use assets 621,612 596,032 Total property, equipment and right-of-use assets 1,240,538 1,200,433 OTHER ASSETS Goodwill 694,292 679,463 Other intangible assets 86,883 90,615 Deferred financing costs 1,483 1,643 Investment in joint ventures 97,034 92,710 Deposits and other 53,497 46,333 Total assets $ 2,969,555 $ 2,690,473 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other $ 324,578 $ 342,940 Due to affiliates 20,494 15,910 Deferred revenue 4,475 4,647 Current operating lease liability 58,138 55,981 Current portion of notes payable 20,202 17,974 Total current liabilities 427,887 437,452 LONG-TERM LIABILITIES Long-term operating lease liability 630,348 605,097 Notes payable, net of current portion 814,442 812,068 Deferred tax liability, net 14,479 15,776 Other non-current liabilities 5,074 6,721 Total liabilities 1,892,230 1,877,114 EQUITY Common stock - $ 0.0001 par value, 200,000,000 shares authorized; 73,901,654 and 67,956,318 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 7 7 Additional paid-in-capital 969,248 722,750 Accumulated other comprehensive loss ( 13,943 ) ( 12,484 ) Accumulated deficit ( 82,357 ) ( 79,578 ) Total RadNet, Inc.'s stockholders' equity 872,955 630,695 Noncontrolling interests 204,370 182,664 Total equity 1,077,325 813,359 Total liabilities and equity $ 2,969,555 $ 2,690,473 The accompanying n

View Full Filing

View this 10-Q filing on SEC EDGAR